Ignite Creation Date:
2025-12-17 @ 9:01 PM
Ignite Modification Date:
2025-12-23 @ 9:02 PM
Study NCT ID:
NCT00735787
Status:
None
Last Update Posted:
2010-11-01 00:00:00
First Post:
2008-08-13 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
Sponsor:
None
Organization:
Study Overview
Official Title:
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
Status:
None
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluate the efficacy and safety of a 16-week course of Humira (adalimumab) compared to placebo in adults with chronic plaque psoriasis of the hands and/or feet and the sustainability of response for 12 additional weeks.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: